1,7-phenanthroline has been researched along with Tauopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aghjayan, SL; Amariglio, RE; Buckley, RF; Hanseeuw, B; Jackson, JD; Johnson, KA; Mormino, EC; Properzi, MJ; Rentz, DM; Schultz, AP; Sperling, RA; Vannini, P | 1 |
1 other study(ies) available for 1,7-phenanthroline and Tauopathies
Article | Year |
---|---|
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Brain; Carbolines; Cognitive Dysfunction; Cross-Sectional Studies; Diagnostic Self Evaluation; Entorhinal Cortex; Female; Frontal Lobe; Humans; Male; Middle Aged; Neocortex; Parietal Lobe; Phenanthrolines; Positron-Emission Tomography; Radiopharmaceuticals; Surveys and Questionnaires; tau Proteins; Tauopathies; Temporal Lobe; Thiazoles | 2017 |